KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Short-term Investments (2016 - 2026)

Regeneron Pharmaceuticals (REGN) has disclosed Short-term Investments for 18 consecutive years, with $5.8 billion as the latest value for Q1 2026.

  • For Q1 2026, Short-term Investments rose 10.11% year-over-year to $5.8 billion; the TTM value through Mar 2026 reached $5.8 billion, up 10.11%, while the annual FY2025 figure was $5.5 billion, 15.9% down from the prior year.
  • Short-term Investments hit $5.8 billion in Q1 2026 for Regeneron Pharmaceuticals, up from $5.5 billion in the prior quarter.
  • Across five years, Short-term Investments topped out at $8.1 billion in Q4 2023 and bottomed at $3.5 billion in Q3 2022.
  • Average Short-term Investments over 5 years is $6.0 billion, with a median of $5.8 billion recorded in 2026.
  • Year-over-year, Short-term Investments soared 126.87% in 2022 and then tumbled 33.57% in 2025.
  • Regeneron Pharmaceuticals' Short-term Investments stood at $4.6 billion in 2022, then surged by 75.02% to $8.1 billion in 2023, then fell by 19.6% to $6.5 billion in 2024, then dropped by 15.9% to $5.5 billion in 2025, then increased by 5.54% to $5.8 billion in 2026.
  • According to Business Quant data, Short-term Investments over the past three periods came in at $5.8 billion, $5.5 billion, and $5.9 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.